Cargando…

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

BACKGROUND: Pregnant women with HIV (PWWH) have high postpartum morbidity and mortality from infections like tuberculosis. Immunologic changes during pregnancy and postpartum periods may contribute to these risks, particularly the immunoregulatory kynurenine pathway of tryptophan catabolism, which c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnittman, Samuel R, Byakwaga, Helen, Boum, Yap, Kabakyenga, Jerome, Matthews, Lynn T, Burdo, Tricia H, Huang, Yong, Tracy, Russell P, Haberer, Jessica E, Kembabazi, Annet, Kaida, Angela, Moisi, Daniela, Lederman, Michael M, Bangsberg, David R, Martin, Jeffrey N, Hunt, Peter W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214017/
https://www.ncbi.nlm.nih.gov/pubmed/34159218
http://dx.doi.org/10.1093/ofid/ofab245
_version_ 1783709972388904960
author Schnittman, Samuel R
Byakwaga, Helen
Boum, Yap
Kabakyenga, Jerome
Matthews, Lynn T
Burdo, Tricia H
Huang, Yong
Tracy, Russell P
Haberer, Jessica E
Kembabazi, Annet
Kaida, Angela
Moisi, Daniela
Lederman, Michael M
Bangsberg, David R
Martin, Jeffrey N
Hunt, Peter W
author_facet Schnittman, Samuel R
Byakwaga, Helen
Boum, Yap
Kabakyenga, Jerome
Matthews, Lynn T
Burdo, Tricia H
Huang, Yong
Tracy, Russell P
Haberer, Jessica E
Kembabazi, Annet
Kaida, Angela
Moisi, Daniela
Lederman, Michael M
Bangsberg, David R
Martin, Jeffrey N
Hunt, Peter W
author_sort Schnittman, Samuel R
collection PubMed
description BACKGROUND: Pregnant women with HIV (PWWH) have high postpartum morbidity and mortality from infections like tuberculosis. Immunologic changes during pregnancy and postpartum periods may contribute to these risks, particularly the immunoregulatory kynurenine pathway of tryptophan catabolism, which contributes to both HIV and tuberculosis pathogenesis and increases in the early postpartum period. METHODS: Women with HIV initiating antiretroviral therapy (ART) in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort who were pregnant at enrollment or became pregnant during observation were studied (n = 54). Plasma kynurenine/tryptophan (KT) ratio, soluble CD14 (sCD14), sCD163, sCD27, interferon-inducible protein 10 (IP-10), D-dimer, interleukin-6, and intestinal fatty-acid binding protein levels were assessed through the first year of ART and at 3-month intervals throughout pregnancy and 1 year postpartum. Biomarker changes were assessed with linear mixed models adjusted for ART duration. Hemoglobin concentration changes were used to estimate pregnancy-related changes in plasma volume. RESULTS: The median pre-ART CD4 count was 134. D-dimer increased through the third trimester before returning to baseline postpartum, while most other biomarkers declined significantly during pregnancy, beyond what would be expected from pregnancy-associated plasma volume expansion. IP-10 and sCD14 remained suppressed for at least 12 months postpartum. KT ratio was the only biomarker that increased above prepregnancy baseline postpartum (mean + 30%; P < .001) and remained higher than baseline for ≥9 months (P ≤ .045 for all time points). CONCLUSIONS: Several immune activation markers decline during pregnancy and remain suppressed postpartum, but the kynurenine pathway of tryptophan catabolism increases above baseline for ≥9 months postpartum. The mechanisms underlying postpartum kynurenine pathway activity are incompletely understood but may contribute to increased tuberculosis risk in this setting.
format Online
Article
Text
id pubmed-8214017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82140172021-06-21 Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection Schnittman, Samuel R Byakwaga, Helen Boum, Yap Kabakyenga, Jerome Matthews, Lynn T Burdo, Tricia H Huang, Yong Tracy, Russell P Haberer, Jessica E Kembabazi, Annet Kaida, Angela Moisi, Daniela Lederman, Michael M Bangsberg, David R Martin, Jeffrey N Hunt, Peter W Open Forum Infect Dis Major Articles BACKGROUND: Pregnant women with HIV (PWWH) have high postpartum morbidity and mortality from infections like tuberculosis. Immunologic changes during pregnancy and postpartum periods may contribute to these risks, particularly the immunoregulatory kynurenine pathway of tryptophan catabolism, which contributes to both HIV and tuberculosis pathogenesis and increases in the early postpartum period. METHODS: Women with HIV initiating antiretroviral therapy (ART) in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort who were pregnant at enrollment or became pregnant during observation were studied (n = 54). Plasma kynurenine/tryptophan (KT) ratio, soluble CD14 (sCD14), sCD163, sCD27, interferon-inducible protein 10 (IP-10), D-dimer, interleukin-6, and intestinal fatty-acid binding protein levels were assessed through the first year of ART and at 3-month intervals throughout pregnancy and 1 year postpartum. Biomarker changes were assessed with linear mixed models adjusted for ART duration. Hemoglobin concentration changes were used to estimate pregnancy-related changes in plasma volume. RESULTS: The median pre-ART CD4 count was 134. D-dimer increased through the third trimester before returning to baseline postpartum, while most other biomarkers declined significantly during pregnancy, beyond what would be expected from pregnancy-associated plasma volume expansion. IP-10 and sCD14 remained suppressed for at least 12 months postpartum. KT ratio was the only biomarker that increased above prepregnancy baseline postpartum (mean + 30%; P < .001) and remained higher than baseline for ≥9 months (P ≤ .045 for all time points). CONCLUSIONS: Several immune activation markers decline during pregnancy and remain suppressed postpartum, but the kynurenine pathway of tryptophan catabolism increases above baseline for ≥9 months postpartum. The mechanisms underlying postpartum kynurenine pathway activity are incompletely understood but may contribute to increased tuberculosis risk in this setting. Oxford University Press 2021-05-17 /pmc/articles/PMC8214017/ /pubmed/34159218 http://dx.doi.org/10.1093/ofid/ofab245 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Schnittman, Samuel R
Byakwaga, Helen
Boum, Yap
Kabakyenga, Jerome
Matthews, Lynn T
Burdo, Tricia H
Huang, Yong
Tracy, Russell P
Haberer, Jessica E
Kembabazi, Annet
Kaida, Angela
Moisi, Daniela
Lederman, Michael M
Bangsberg, David R
Martin, Jeffrey N
Hunt, Peter W
Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
title Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
title_full Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
title_fullStr Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
title_full_unstemmed Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
title_short Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
title_sort changes in immune activation during pregnancy and the postpartum period in treated hiv infection
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214017/
https://www.ncbi.nlm.nih.gov/pubmed/34159218
http://dx.doi.org/10.1093/ofid/ofab245
work_keys_str_mv AT schnittmansamuelr changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT byakwagahelen changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT boumyap changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT kabakyengajerome changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT matthewslynnt changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT burdotriciah changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT huangyong changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT tracyrussellp changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT habererjessicae changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT kembabaziannet changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT kaidaangela changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT moisidaniela changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT ledermanmichaelm changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT bangsbergdavidr changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT martinjeffreyn changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection
AT huntpeterw changesinimmuneactivationduringpregnancyandthepostpartumperiodintreatedhivinfection